Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Your search for XIST returned no results
Showing 1531 to 1545 of 1556 results for list

  1. Digital mental health tech for children and young people recommended by NICE in first rapid healthtech guidance

    Four digital technologies that can help children and young people with mild to moderate symptoms of anxiety or low mood have been recommended for use in the NHS.

  2. Seven technologies recommended to help people with non-specific low back pain

    People with non-specific low back pain could be offered apps to help them manage their condition after seven digital technologies were recommended in draft guidance.

  3. New treatment for acute migraine set to benefit thousands

    The first in a new class of treatment to be recommended by NICE for treating acute migraine will soon be available on the NHS to around 13,000 people.

  4. NICE recommended personalised immunotherapy to treat blood cancer in children and young adults to be made routinely available on the NHS

    Innovative CAR-T therapy recommended to treat an aggressive form of leukaemia.

  5. NICE's Early Value Assessment for Medtech: panning for nuggets of innovation gold

    Early Value Assessment for Medtech and how it will offer a rapid assessment of digital products, devices and diagnostics for clinical effectiveness and value for money.

  6. NICE approves life-changing gene therapy for treating spinal muscular atrophy

    A new one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by NICE.

  7. First gene therapy for rare genetic neurodegenerative disorder in children, recommended in NICE draft guidance

    Children with a rare, fatal, genetic disorder will be able to benefit from a new one-off treatment under new NICE guidance.

  8. Routine funding recommended for Duchenne muscular dystrophy gene therapy ataluren

    NICE has today published final guidance which recommends ataluren (also called Translarna and made by PTC Therapeutics) for treating Duchenne muscular dystrophy (DMD) caused by a nonsense mutation.

  9. Artificial intelligence to speed up contouring in radiotherapy treatment planning

    Nine artificial intelligence technologies can be used to help plan the treatment of those undergoing external beam radiotherapy for cancers

  10. A safe space for bold ideas – implementing a sandbox approach in health technology assessment

    Colleagues in our Science Policy and Research Programme discuss their international research, paving the way for next generation health technology assessment.

  11. Master healthcare decision-making with LSE and NICE

    Lead with confidence through our Executive MSc in Healthcare Decision-Making.

  12. Introducing CHEERS-AI: improving health economic evaluation reporting for AI technologies

    Our contribution to world-leading research.

  13. NICE publishes single guideline for managing COVID-19

    One year on from the first national lockdown, NICE has today (23 March) published a single guideline for the management of COVID-19 in children and adults.

  14. Speaking with one language: How using a common data model might speed up decision making

    The European Health Data and Evidence Network (EHDEN) project could support faster patient access to innovative medicines in areas of unmet need.

  15. Around 100,000 fewer colonoscopies expected to take place each year

    Tens of thousands of people a year could be spared the need for a colonoscopy following new guidance from NICE.